Search
for
Sort by
Research 691–720 of 1000+
- Novel causes of drug-induced occupational asthma
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability
- Niosomes: A Novel Targeted Drug Delivery System
- DNN-DTIs: improved drug-target interactions prediction using XGBoost feature selection and deep neural network
- [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- The novel drug CS-891 inhibits 5alpha-reductase activity in freshly isolated dermal papilla of human hair follicles.
- [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
- The Effect of the Drug Minoxidil on Hair Growth
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Composite HydrogelDressing with Drug-Release Capabilityand Enhanced Mechanical Performance
- Preparation of ROS‐Responsive Drug‐Loaded Particles and Microneedles for Diabetic Wounds Healing
- Disease modifying osteoarthritis drug discovery using a temporal phenotypic reporter in 3D aggregates of primary human chondrocytes
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Utility of homoeopathic drug phosphorus in management of alopecia areata: An evidence based case report
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis